A carregar...
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Histone deacetylase inhibitors (HDIs) are a group of potent epigenetic drugs which have been investigated for their therapeutic potential in various clinical disorders, including hematological malignancies and solid tumors. Currently, several HDIs are already in clinical use and many more are on cli...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6406474/ https://ncbi.nlm.nih.gov/pubmed/30691229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11020148 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|